The nation’s largest radiology practice is introducing an AI-based service that can warn women of looming cardiovascular risk whenever they receive a routine screening mammogram.
Some of today’s large language models may be more effective communicators than providers when it comes to explaining interventional radiology procedures.
The U.S. Food and Drug Administration highlighted concerns about "data drift," which can potentially lead to performance degradation, bias or reduced reliability.
Although DBT exams are proven to identify more difficult to detect cancers, especially among women with dense breasts, they also include significantly more images than standard 2D mammograms.
The company made the announcement following the 1,111th installation of its BlueSeal 1.5T magnet, which took place at the Vida Imaging and Breast Center in Bayamón, Puerto Rico.
An updated version of Heartflow's Plaque Analysis platform has gained FDA clearance. In addition, the company announced that Cigna will cover the platform going forward.
Several groups collaborated on the document, which is designed to help clinicians provide high-quality, consistent care when using flurpiridaz during cardiac PET imaging exams.
